Such dynamic DUX4 up-regulation may contribute to the modest efficacy of DUX4 target gene expression as a biomarker in FSHD muscle biopsies (32), but this could be in combination with contributions from DUX4 expressing immune cells. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.